Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country

  • Alexander A. Martínez,

    Affiliations Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama, Department of Biotechnology, Acharya Nagarjuna University, Guntur City, Andhra Pradesh, India, INDICASAT-AIP, Clayton, City of Knowledge, Panama

    ⨯
  • Yamitzel Zaldívar,

    Affiliation Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama

    ⨯
  • Griselda Arteaga,

    Affiliations Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama, Department of Microbiology, School of Medicine, University of Panama, Panama City, Panama, Panama

    ⨯
  • Zoila de Castillo,

    Affiliation Nucleic Acid Test Unit, Complejo Hospitalario Dr. Arnulfo Arias Madrid, Caja de Seguro Social, Panama City, Panama

    ⨯
  • Alma Ortiz,

    Affiliation Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama

    ⨯
  • Yaxelis Mendoza,

    Affiliations Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama, Department of Biotechnology, Acharya Nagarjuna University, Guntur City, Andhra Pradesh, India, INDICASAT-AIP, Clayton, City of Knowledge, Panama

    ⨯
  • Omar Castillero,

    Affiliation Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama

    ⨯
  • Juan A. Castillo,

    Affiliation Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama

    ⨯
  • Juan Cristina,

    Affiliation Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Igua, Montevideo, Uruguay

    ⨯
  • Juan M. Pascale

    jpascale@gorgas.gob.pa

    Affiliations Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama, Panama, Department of Microbiology, School of Medicine, University of Panama, Panama City, Panama, Panama

    ⨯

Abstract

The Hepatitis B Virus (HBV) can cause acute or chronic infection it is also associated with the development of liver cancer, thousands of new infections occur on a yearly basis, and many of these cases are located in certain areas of the Caribbean and Latin America. In these areas, the HBV prevalence is still high which makes this virus a serious public health concern to the entire region. Studies performed in Panama suggest a complex pattern in the distribution of HBV among the country’s different risk groups. We use phylogenetic analysis in order to determine which HBV genotypes were circulating in these specific groups; for this we used a fragment of the PreS2/2 region of the HBV genome. Subsequently whole HBV genome sequences were used for Bayesian analysis of phylodynamics and phylogeography. Two main genotypes were found: genotype A (54.5%) and genotype F (45.5%). There was a difference in the distribution of genotypes according to risk groups: 72.9% of high risk groups were associated to genotype A, and 55.0% of samples of genotype F were associated to the low risk group (p<0.002). The Bayesian analysis of phylogeny-traits association revealed a statistically significant geographical association (p<0.0001) with both genotypes and different regions of the country. The Bayesian time of most recent common ancestor analysis (tMRCA) revealed a recent tMRCA for genotype A2 circulating in Panama (1997, 95% HPD: 1986—2005), when it is compared with Panamanian genotype F1c sequences (1930, 95% HPD: 1810 – 2005). These results suggest a possible change in the distribution of HBV genotypes in Panama and Latin America as a whole. They also serve to encourage the implementation of vaccination programs in high-risk groups, in order to prevent an increase in the number of new HBV cases in Latin America and worldwide.

Citation: Martínez AA, Zaldívar Y, Arteaga G, de Castillo Z, Ortiz A, Mendoza Y, et al. (2015) Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country. PLoS ONE 10(7): e0134850. https://doi.org/10.1371/journal.pone.0134850

Editor: Isabelle A. Chemin, CRCL-INSERM, FRANCE

Received: May 9, 2015; Accepted: July 14, 2015; Published: July 31, 2015

Copyright: © 2015 Martínez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: The sequences used in this study were deposited in Genbank under the accession numbers KP718063 to KP718113.

Funding: This study was supported by GRANT FID09-050, Secretaria Nacional de Ciencia y Tecnología (SENACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Hepatitis B Virus (HBV) is a major cause of serious liver disease [1]. The virus can cause acute or chronic infection and is commonly associated with the development of liver cancer. Although an effective vaccine for HBV was approved over a decade ago, there are still thousands of new infections occurring every year, many of these cases are located in certain areas of Asia, Africa and the Caribbean where the HBV prevalence is high, making this virus a serious public health concern [2].

In Panama, HBV prevalence rates vary according to the population being studied. Commercial sex workers (CSW) show a low prevalence (0.9%) [3]; men that have sex with men (MSM) have an intermediate prevalence (3.4%) [4], while blood donors have the lowest prevalence (0.03%) [5]. These differences in HBV prevalence between the different groups has also been observed in other countries [6–16]. This could serve as an indication that some individuals are at a higher risk for acquiring the infection [17], resulting in a particular pattern of distribution among groups, or an expansion of best fitted virus strains among different HBV genotypes circulating in the country [18].

HBV is classified in genotypes A to I according to divergences greater than 8% in its genome [19]. Several studies suggest that the distribution of the HBV genotypes is associated with worldwide human migration [20–22]. Additionally, recent studies have demonstrated that the local circulation of HBV genotypes also have components that are related to ethnicity and risk behaviors [9,23,24]. Bayesian studies have revealed that genotype F has a long history of local circulation within Latin America [25–28], however, recent surveys have reported the circulation of genotypes A, B, C, D [29,30], and the presence of recombinant forms of genotype A and F in the region [31] across the continent [15,32–38]. These findings suggest new dynamics in the circulation of HBV genotypes and the introduction of new genotypes in Central and South America.

To explore the hypothesis that the circulation of HBV genotypes in Panama are not only associated with geographic location, but also with population behaviors, we evaluated the prevalence of different HBV genotypes from three cohorts of different Panamanian subjects, stratified by geographic origin and transmission risk factor. The purpose of this study was to evaluate the possible association of HBV genotypes to explore the probable origin of the genotypes circulating in the country and with different possible risk groups.

Materials and Methods

Ethics statement

The study was evaluated and approved by the Gorgas Memorial Institute Review Board. All subjects signed informed written consent and were in agreement with the use of their samples for additional studies.

Sampling

We evaluated positive samples of HBsAg from three different risk groups: commercial sex workers (CSW) (n = 6), men that have sex with men (MSM) (n = 28), and HIV positive subjects (n = 34). All these samples were obtained during an epidemiologic study of HIV and STD in Panama, which was carried out from 2010 to 2013. HBV-DNA positive samples from blood donors (n = 88) (a low risk group) were also analyzed. Samples from blood donors were obtained from a previously described study [27].

Molecular analysis

DNA was extracted from plasma (300μL) using Qiamp Reagent according to the manufactured procedure (Qiagen CA). The HBV viral load was quantified by using a previously described method [39]. Samples with more than 2,000 viral copies/ml were subjected to a nested PCR to amplify a portion (879 bp) of the HBV genome (nucleotides 221 to 1100 relative to reference AB036910 strain) which allowed us to differentiate HBV at the sub-genotype level [27].

The HBV genotype was first determined by using a web-based program [40] and confirmed by phylogenetic analysis. A dataset with the Panamanian HBV sequences and HBV reference sequences, obtained from Genbank, were aligned by using Muscle v3.8.31 [41]. Maximum Likelihood (ML) phylogenetic trees were inferred under GTR+I+Γ nucleotide substitution model which was selected by using the jModeltest program [42]. The ML tree was reconstructed with the PhyML program, for which we used an online web server [43]. The reliability of the obtained topology was estimated by using an approximate likelihood-ratio test (αLTR) based on the Shimodaira-Hasegawa-like procedure [44]. The obtained tree was visualized in FigTree v1.4.2 (available at http://tree.bio.ed.ac.uk/software).

Nucleotide changes in PreS2-S, HBsAg, Basal Core Promoter region (BPC), preCore and X gene regions (X/preC) and amino acid substitutions in polymerase, were determined by evaluating the Panamanian nucleotide sequences or the translated sequence against reference genotypes using MEGA 5.2 [45].

Amplification of the full-length genome of Panamanian sequences were carried out using primers P1 and P2 published elsewhere [46]. Samples with low viral load copy (<10,000 copies/ml) were amplified through the use of a nested PCR protocol [26].

Correlation of the HBV phylogeny with geographical and risks behavioral traits

In order to test for statistical significance in the observed phylogeny-trait association of high risk groups and geographic location in Panama, a Bayesian Tip-Significant test (BaTS) [47] was applied. The dataset consisted of 88 Panamanian sequences, 879 bp long. A set of 200 trees, representing the phylogenetic structure of the sequences of the HBV strains circulating in the country, was obtained using BEAST v1.8 [48], the parameters of the analysis were the following: GTR+I+Γ substitution model, with 50 million MCMC computed states, and the sampling of trees every of about 200,000 generations, after 20% of burn-in. Each sequence was labeled with its corresponding risk group and geographic location. The Association index (AI), the parsimony score statistics (PS), and the monophyletic clade size statistics (MC) (from the 200 trees) were calculated with BaTS and the null distributions of each statistic were obtained with 1000 random permutations.

Bayesian analysis of population history and phylogeography analysis of the genotypes F and A

Whole genome HBV sequences obtained at different times were used to estimate the evolutionary rates (μ, nucleotide substitutions per site per year, s/s/y), and the time to the most common recent ancestor (Tmrca, years) of the Panamanian sequences with a dataset from the genotype F (n = 94) classified by sub-genotypes: F1a (n = 3), F1a-pan (n = 2), F1b (n = 24), F1c-pan (n = 7), F2 (n = 9), F3 (n = 32), F4 (n = 15), F5-pan (n = 2) and a dataset from the genotype A (n = 271) also classify by sub-genotype as follow: A1 (n = 71), A2 (n = 161), A3 (n = 37), A4 (n = 2). To infer the tMRCA of these sub-genotypes we used time-stamped data and an intermediate rate of substitution (1.0 x 10−5 s/s/y) as was suggested by Torres et. al [26]. To test the hypothesis that the Panamanian sequences have a similar origin, we studied the spatial diffusion of the Panamanian samples obtained in this study evaluating the phylogeography of the complete genome sequences of genotype F, genotype A and sub-genotype A2. For the genotype F the database was based on sequences previously published [26], and sequences of Panamanian origin. For the genotype A and A2, sequences were retrieved in May 2014 from Genbank, the accession numbers, collection dates, and location data of the used sequences are in S1 File. The sequences were then evaluated with RDP4 software to discard recombinants [49], additionally, sequences with a common origin (i.e.: nosocomial outbreaks) were discarded. The final datasets consisted of 94 sequences for genotype F, 116 sequences for genotype A. Both datasets had geographic location information and sampled dates, and 139 sequences for sub-genotype A2 with just geographic location information. All alignments are available upon request. The evolutionary rates, the tMRCA and the spatial diffusion were calculated simultaneously in BEAST v1.8. We used a partitioned model of the whole genome of HBV, with different substitutions models according to the region of the HBV genome [28]. A relaxed uncorrelated lognormal model was used as molecular clock, a Bayesian skyline plot as a tree model [50] and a reversible discrete diffusion model was used [51] for the analysis of phylogeography. The MCMC chains were run for 200 million of generations and the convergence (ESS>200) was evaluated in TRACER v1.6. The obtained trees were summarized with Tree annotator v1.8 and the Maximum credibility tree was visualized in FigTree v.1.42 (available at http://tree.bio.ed.ac.uk/software).

The sequences used in this study were deposited in Genbank under the accession numbers KP718063 to KP718113

Results

The distribution of HBV genotypes in Panama is significantly associated with the geographic location

In this study we evaluated the HBV genotypes that are circulating in four different Panamanian populations of HBV positive subjects. We grouped these populations into two risk levels: low risk (blood donors) and high risk (CSW, MSM, HIV positive subjects). A total of 156 HBsAg positive subjects were included in the study and 88 partial PreS2-S sequences were obtained from them. Genotype A was the most prevalent and detected in 48 (54.5%) subjects, followed by genotype F in 40 (45.5%) participants (Fig 1). When we grouped the sequences according to the risk of acquiring the infection, we obtained the following results: the low risk group showed a significant association with genotype F (n = 22, 55%), however, high risk groups showed a significant association with genotype A (n = 35, 72.9%) (p<0.002) Table 1. When the samples were analyzed according to geographical location, associations were noted for the genotype F in Western provinces of Panama (n = 21, 81%), whereas genotype A was concentrated in the central areas of the country (n = 37, 75.5%). Table 1 (Fig 2).

thumbnail
Download:
Fig 1. Maximum Likelihood tree of HBV Panamanian sequences.

The tree is based on HBV partial PreS2-S region (~820pb), using reference sequences of each genotype (A-I) (n = 280) and sequences of Panamanian origin (n = 88) which are colored in blue. The place of sample collection is indicated in the taxa name, the symbols represent the behavioral risk groups to which the sample belongs: bold triangle: low risk, bold hexagon: high-risk group (bold circle). Clades in which there are not Panamanian samples are collapsed to simplify, node numbers correspond to αLTR values higher than 0.75.

https://doi.org/10.1371/journal.pone.0134850.g001

thumbnail
Download:
Fig 2. Map of Panama indicating the origin of the HBV sequences analyzed in this study.

The number of sequences according to the genotype is indicated in the top left pie chart, the middle bar plot indicates the number of genotypes according to geographic area. Pie charts within the map are sized by the proportion of sub-genotype found in the corresponding region.

https://doi.org/10.1371/journal.pone.0134850.g002

thumbnail
Download:
Table 1. Genotype distribution of the HBV sequences evaluated according to risk behavior group, geographic location and the mutations found in BCP, X/PreC and Polymerase.

https://doi.org/10.1371/journal.pone.0134850.t001

During sub-genotype analysis the tree topology formed by the sub-genotype A2 and sub-genotype F3 sequences showed a probable association with high-risk traits. In order to evaluate trait diffusion among high-risk groups and geographic location, a Bayesian association-tips significant test (BaTS) was implemented with all the Panamanian sequences generated by this study (n = 88). The analysis showed a significant spatial phylogeography structure in the Panamanian sequences (p< 0.005), with significant clustering of genotype A in Panama City and genotype F in the western region of the country in Changuinola Table 2. The analysis of association with risk to acquire infection showed no statistically significant clustering among risk groups, therefore, the results do not discard the possibility that the observed high-risk association with genotype A could have been a result of coincidence (p >0.05) Table 2.

thumbnail
Download:
Table 2. Bayesian phylogeny-traits association results, according to risk behavior group and geographic location.

https://doi.org/10.1371/journal.pone.0134850.t002

Recent population history from Panamanian samples of HBV genotype A

To estimate the rates of nucleotide substitutions and the tMRCA of genotype A and F, we used a Bayesian coalescence approach under an uncorrelated lognormal relaxed molecular clock with a Bayesian skyline tree model. This model showed the best descriptions of the evolutionary history of HBV [5,26]. For genotype A, the mean rate of substitutions 4.39x10-04 subs/site/year (95% HPD, 2.2 x 10−4–7.0 x 10−4) were higher than the mean rates for the genotype F, 1.20 x 10−04 subs/site/year (95% HPD, 7.0 x 10−6, 2.0 x 10−4) with no overlap among HPD intervals Table 3. The analysis of tMRCA of genotype F confirms previous estimates of tMRCA for each sub-genotype (Table 3), but when Panamanian samples of sub-genotype F1a were evaluated (F1a pan in Table 3), we observed younger tMRCA compared with others genotype reported in America: F1a, F2, F3, F4, and even with sub-genotype F1c and F5 that were also reported in Panama.

thumbnail
Download:
Table 3. Estimated of tMRCA and substitution rate for Genotype A and F, with the HBV Whole genome of the Panamanian samples.

https://doi.org/10.1371/journal.pone.0134850.t003

The tMRCA analysis of the sub-genotype A2 showed that the MRCA of this sub-genotype dated around 1997 (1986–2005) (Fig 3A). This result contrasts with the older circulation dates for the MRCA of the Panamanian genotype F: 1930 (1810–2005) for the genotype F1c, and 1960 (1915–2009) for the genotype F3 (Fig 3B).

thumbnail
Download:
Fig 3. MCC trees showing the time resolved phylogenies of the Panamanian samples.

The tree was draw using the whole genome sequences of the Panamanian samples and sequences published elsewhere for genotypes A (a) and F (b). The date of MRCA is shown in the node of relevant sub-genotypes and nodes formed by Panamanian samples (shadowed). The most probable location states of each node are indicated by colored circles, the circles are sized by state posterior probability. The thickness of the Branch lines indicates the Bayesian posterior probabilities of each clade branch with the lower value set as 1 and the higher as 3 in Figtree. *Indicates the monophyletic clade analyzed in the tMRCA analysis.

https://doi.org/10.1371/journal.pone.0134850.g003

Different geographic origin of genotype F and genotype A2 in Panama

The most probable circulation place for Genotype F is the American continent (Fig 4B). Particularly in Panama, there is circulation of genotypes F3, F1a, F1c and F5. Phylo-geographic results for Sub-genotype F3 suggest a circulation of this sub-genotype among Venezuela, Panama, and Colombia (Fig 4A), with a similar tMRCA for all these F3 sequences (Table 3). However, the sub-genotype F1c and sub-genotype F5 are exclusively located in Panama. The sub-genotype F1c has a more recent tMRCA compared with F5, but with a 95% HPD overlap between its tMRCA confidence intervals.

thumbnail
Download:
Fig 4. Spatial dissemination of HBV genotypes across the world.

Lines between countries represent sequences in which transition location occurs, and were supported by a significant non-zero rate (Bayes Factor >3). Map (a) is for genotype F (a), and map (b) for genotype A. Lines were colored according to the sub-genotype involved in the migration.

https://doi.org/10.1371/journal.pone.0134850.g004

When we analyzed the geographical origin of genotype A, in Panama this genotype seems to have a different origin from the one of genotype F (Fig 3A and 3B). The sub-genotype A1 found in Panama have a significant association with strains circulating in Central Africa, instead the sub-genotype A2 have relation with strains circulating in Europe and Russia (Fig 4B).

Discussion

The HBV genotypes circulation in Panama depends mainly on the geographic location of the samples. The association of genotypes with risk groups was not confirmed by Bayesian phylogenetic analysis. Although studies performed in countries such as Japan, United States and Belgium suggested an increased prevalence of genotype A2 in acute infections and in high-risk groups [14,52–54], our data did not support statistically significant monophyletic clades association, with HBV genotype circulation in MSM or other behavioral risk traits. When we compare the genotype distribution in the present study with a previous study that included only Panamanian blood donors (low risk group) [5], a difference in prevalence of genotype F and A was clearly observed. The differences in genotype distribution suggest that there is an association between risk behavior and HBV genotypes in Panama.

Sub-genotype analysis showed differences in the HBV genotype circulation in the country; with genotypes A2 and F3 located in Panama City while the recently described genotypes F1c and F5 in the western areas of Panama. These results are of extreme importance, because based on previous studies Panamanian samples of genotypes F had a higher proportion of mutations related with the development of hepatocellular carcinoma in the BCP and X/PreC regions [27]. Therefore, subjects infected in the western areas of Panama had a greater chance of being infected with a virus variant that basically has a much higher probability of inducing the development of hepatocellular carcinoma [55,56].

In the present study we also found that most of the samples from HIV positive individuals with antiretroviral resistance mutations were infected with genotype A, a situation that was observed in countries such as Japan [14] and The Netherlands [57]. This suggests that HIV positive subjects who are co-infected with HBV in both Panama City and elsewhere must be evaluated for resistant mutations before initiating treatment.

Previous studies demonstrated that genotype F is in fact the oldest genotype circulating in the Americas [26,27]. In a previous study, we reported a tMRCA for genotype F1c (1911, HPD95% 1636–1975) [5] which is in agreement with the historical period of high population density during the construction of the Panama Canal [58] In the present study, we observed a recent tMRCA for genotype A2, and for sub-genotype F1a circulating in Panama. These results evidence the co-circulation of different HBV genotypes in Panama and suggest a possible recent introduction of genotype A2 and F1a in the country. In addition, the higher substitution rates observed in genotype A samples, could be the result of an increased number of susceptible hosts, as is the case of Panamanian MSM subjects, where the risk of acquired sexually transmitted diseases is increased [4]

The recent introduction of sub-genotype F1a in Panama, suggests the possibility that there is a beginning of dissemination of this HBV sub-genotype from Central America to South America. There is a need to perform studies aimed to evaluate circulation of HBV genotypes circulating in Central America and Mexico to better explain the spatial diffusion of this sub-genotype in the population of this part of the continent.

The phylogeography analysis we are presenting confirms the circulation of genotype F across the American continent, this observation together with the similar tMRCA results for sub-genotypes of genotype F, supports the hypothesis of early spread of genotype F in the continent after its origin from a common ancestor several years ago. Additionally, the extended worldwide migration of genotype A, especially genotype A2 supports a panmixis hypothesis of genotype A2 across the world. Moreover, there is an increasing evidence of a recent expansion of the genotype A2 in different areas of the world. For example, in Japan a steady increase in genotype A2 cases has been observed in HIV positive MSM subjects [14]. However, in the United States, the expansion of the genotype A2 has been observed in acute infections [59]. Therefore, the growing number of cases of genotype A2 in Panama could be part of a global increase in the circulation of the genotype A2. This is particularly important because we found that genotype A has a slightly higher level of nucleotide substitution rates (Table 3) when compared to genotype F. This could lead to a potential increase in the emergence of new variants with effective transmission in susceptible subjects.

Conclusion

We found that HBV genotype distribution in Panama is changing. There has been a recent increase in the circulation of genotype A in the country, and the emergence of mutations that could change the clinical prognosis of the infection for both genotypes A and F. Implementation of vaccination programs in high risk groups should be a priority in the region in order to avoid further increases in the number of new HBV cases. This could also reduce the potential increase of genotype A distribution in Latin America and the world.

Supporting Information

S1 File. Data of the sequences analyzed*.

*Panamanian sequences generated in this study are shown in bold. n/i: No information).

https://doi.org/10.1371/journal.pone.0134850.s001

(PDF)

Acknowledgments

We would like to give thanks to our collaborators at Gorgas Memorial Institute for Health Studies for the managing of samples, Migdalys Ortega, Lauris De Leon. Also, Dr. Rigoberto Samaniego and Dra. Amalia Rodriguez French from the Santo Tomas Hospital. We would also like to thank Amanda Gabster for her helpful comments on the proper usage of the English language.

Author Contributions

Conceived and designed the experiments: AM JP. Performed the experiments: AM JAC AO OC YZ. Analyzed the data: AM JC JP. Contributed reagents/materials/analysis tools: ZC YM. Wrote the paper: AM JC JP. Carried out and supervised the epidemiological surveys and the serological testing: GA.

References

  1. 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011/02/08 ed. 61: 69–90. pmid:21296855
  2. 2. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 30: 2212–9. pmid:22273662
  3. 3. Hakre S, Arteaga G, Núñez AE, Bautista CT, Bolen A, Villarroel M, et al. Prevalence of HIV and other sexually transmitted infections and factors associated with syphilis among female sex workers in Panama. Sex Transm Infect. 89: 156–64. pmid:23002191
  4. 4. Hakre S, Arteaga G, Núñez A, Arambu N, Aumakhan B, Liu M, et al. Prevalence of HIV, Syphilis, and Other Sexually Transmitted Infections among MSM from Three Cities in Panama. J Urban Heal. Springer US; 91: 793–808.
  5. 5. Martínez A a, Zaldivar YY, De Castillo Z, Ortiz AY, Mendoza Y, Cristina J, et al. High diversity of hepatitis B virus genotypes in panamanian blood donors: a molecular analysis of new variants. PLoS One. 9: e103545. pmid:25093674
  6. 6. Pollack HJ. Screening for chronic hepatitis B among Asian/Pacific Islander populations—New York City, 2005. MMWR Morb Mortal Wkly Rep. 2006/05/13 ed. 55: 505–509.
  7. 7. Kowdley K V, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 56: 422–33. pmid:22105832
  8. 8. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HLA, Terrault NA, et al. Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype. Clin Gastroenterol Hepatol.
  9. 9. Bini EJ, Perumalswami P V. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions. Hepatology. 2010/02/09 ed. 51: 759–766. pmid:20140950
  10. 10. Carobene M, Bolcic F, Farías MSDR, Quarleri J, Avila MM. HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina. J Med Virol. 86: 64–70. pmid:24123155
  11. 11. Chow EPF, Tucker JD, Wong FY, Nehl EJ, Wang Y, Zhuang X, et al. Disparities and risks of sexually transmissible infections among men who have sex with men in China: a meta-analysis and data synthesis. PLoS One. 9: e89959. pmid:24587152
  12. 12. Kojima Y, Kawahata T, Mori H, Furubayashi K, Taniguchi Y, Iwasa A, et al. Prevalence and epidemiological traits of HIV infections in populations with high-risk behaviours as revealed by genetic analysis of HBV. Epidemiol Infect. Cambridge University Press; 141: 2410–7. pmid:23347648
  13. 13. Price H, Bansi L, Sabin C a, Bhagani S, Burroughs A, Chadwick D, et al. Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study. PLoS One. 7: e49314. pmid:23145150
  14. 14. Fujisaki S, Yokomaku Y, Shiino T, Koibuchi T, Hattori J, Ibe S, et al. Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan. J Clin Microbiol. 49: 1017–24. pmid:21248087
  15. 15. Lama JR, Agurto HS, Guanira J V, Ganoza C, Casapia M, Ojeda N, et al. Hepatitis B infection and association with other sexually transmitted infections among men who have sex with men in Peru. Am J Trop Med Hyg. 83: 194–200. pmid:20595501
  16. 16. Van Houdt R, Bruisten SM, Speksnijder AGCL, Prins M. Unexpectedly high proportion of drug users and men having sex with men who develop chronic hepatitis B infection. J Hepatol. European Association for the Study of the Liver; 57: 529–33.
  17. 17. Holmes EC, Zhang LQ, Robertson P, Cleland A, Simmonds P, Brown AJL, et al. The Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Edinburgh. J Infect Dis. 171: 45–53. pmid:7798682
  18. 18. Duffy S, Shackelton L a, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet. 9: 267–76. pmid:18319742
  19. 19. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988/10/01 ed. 69 (Pt 10: 2575–2583.
  20. 20. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005/03/09 ed. 23: 2409–2423. pmid:15752827
  21. 21. Kramvis A, Paraskevis D. Subgenotype A1 of HBV–tracing human migrations in and out of Africa. Antivir Ther. 18: 513–521. pmid:23792935
  22. 22. Andernach IE, Nolte C, Pape JW, Muller CP. Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa. Emerg Infect Dis. 15: 1222–8. pmid:19751583
  23. 23. Sakurai M, Sugauchi F. Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii. World J Gastroenterol. 10; 2218–2222. pmid:15259069
  24. 24. Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res. 2010/02/17 ed. 40: 14–30. pmid:20156297
  25. 25. Venegas M, Alvarado-Mora M V, Villanueva RA, Rebello Pinho JR, Carrilho FJ, Locarnini S, et al. Phylogenetic analysis of hepatitis B virus genotype F complete genome sequences from Chilean patients with chronic infection. J Med Virol. 2011/07/09 ed. 83: 1530–1536. pmid:21739442
  26. 26. Torres C, Piñeiro y Leone FG, Pezzano SC, Mbayed VA, Campos RH. New perspectives on the evolutionary history of hepatitis B virus genotype F. Mol Phylogenet Evol. 59: 114–22. pmid:21296172
  27. 27. Martínez AA, Zaldivar YY, De Castillo Z, Ortiz AY, Mendoza Y, Cristina J, et al. High Diversity of Hepatitis B Virus Genotypes in Panamanian Blood Donors: A Molecular Analysis of New Variants. PLoS One. Public Library of Science; 9: e103545. pmid:25093674
  28. 28. Bouckaert R, Alvarado-Mora M V, Pinho JRR. Evolutionary rates and HBV: issues of rate estimation with Bayesian molecular methods. Antivir Ther. 18: 497–503. pmid:23792904
  29. 29. Santos AO, Alvarado-Mora M V, Botelho L, Vieira DS, Pinho JRR, Carrilho FJ, et al. Characterization of hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil. Virol J. 7: 315. pmid:21073730
  30. 30. Alvarado Mora M V, Romano CM, Gomes-Gouvea MS, Gutierrez MF, Botelho L, Carrilho FJ, et al. Molecular characterization of the Hepatitis B virus genotypes in Colombia: a Bayesian inference on the genotype F. Infect Genet Evol. 2010/10/19 ed. 11: 103–108. doi:S1567-1348(10)00284-4 [pii] pmid:20951841
  31. 31. Alvarado-Mora M V, Romano CM, Gomes-Gouvea MS, Gutierrez MF, Carrilho FJ, JR RP. Phylogenetic analysis of complete genome sequences of hepatitis B virus from an Afro-Colombian community: presence of HBV F3/A1 recombinant strain. Virol J. 2012/10/25 ed. 9: 244. [pii] pmid:23092209
  32. 32. Garcia-Montalvo BM, Ventura-Zapata LP. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Ann Hepatol. 2011/04/20 ed. 10: 133–141. pmid:21502674
  33. 33. Roman S, Tanaka Y, Khan A, Kurbanov F, Kato H, Mizokami M, et al. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol. 2010/07/22 ed. 82: 1527–1536. pmid:20648606
  34. 34. Alvarado-Esquivel C, Sablon E, Conde-Gonzalez CJ, Juarez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S. Molecular analysis of hepatitis B virus isolates in Mexico: predominant circulation of hepatitis B virus genotype H. World J Gastroenterol. 2006/10/31 ed. 12: 6540–6545. pmid:17072988
  35. 35. Campos RH, Mbayed VA, Pineiro YLFG. Molecular epidemiology of hepatitis B virus in Latin America. J Clin Virol. 2006/02/08 ed. 34 Suppl 2: S8–S13. pmid:16461245
  36. 36. Sánchez L V, Tanaka Y, Maldonado M, Mizokami M, Panduro a. Difference of hepatitis B virus genotype distribution in two groups of mexican patients with different risk factors. High prevalence of genotype H and G. Intervirology. 50: 9–15. pmid:17164552
  37. 37. Arauz-Ruiz P, Norder H, Visoná K a, Magnius LO. Molecular epidemiology of hepatitis B virus in Central America reflected in the genetic variability of the small S gene. J Infect Dis. 176: 851–8. pmid:9333141
  38. 38. Arauz-Ruiz P, Norder H, Visona KA, Magnius LO. Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry the precore stop mutant. J Med Virol. 51: 305–312. pmid:9093945
  39. 39. Paraskevis D, Beloukas A, Haida C, Katsoulidou A, Moschidis Z, Hatzitheodorou H, et al. Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA. Virol J. 2010/03/17 ed. 7: 57. pmid:20226057
  40. 40. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res. 2004/06/25 ed. 32: W654–9. [pii] pmid:15215470
  41. 41. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004/08/21 ed. 5: 113. pmid:15318951
  42. 42. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods. 9: 772–772.
  43. 43. Guindon S, Lethiec F, Duroux P, Gascuel O. PHYML Online—a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res. 2005/06/28 ed. 33: W557–9. pmid:15980534
  44. 44. Shimodaira H. An approximately unbiased test of phylogenetic tree selection. Syst Biol. 2002/06/25 ed. 51: 492–508. pmid:12079646
  45. 45. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 28: 2731–9. pmid:21546353
  46. 46. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol. 1995/09/01 ed. 69: 5437–5444. pmid:7636989
  47. 47. Parker J, Rambaut A, Pybus O. Correlating viral phenotypes with phylogeny: accounting for phylogenetic uncertainty. Infect Genet Evol. 8: 239–246. pmid:17921073
  48. 48. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 29: 1969–73. pmid:22367748
  49. 49. Martin D, Rybicki E. RDP: detection of recombination among aligned sequences. Bioinformatics. 16: 562–563. pmid:10980155
  50. 50. Drummond AJ, Rambaut A, Shapiro B, Pybus OG. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol. 22: 1185–92. pmid:15703244
  51. 51. Lemey P, Rambaut A, Drummond AJ, Suchard M a. Bayesian phylogeography finds its roots. PLoS Comput Biol. 5: e1000520. pmid:19779555
  52. 52. Koibuchi T, Hitani A, Nakamura T, Nojiri N, Nakajima K, Jyuji T, et al. Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan. J Med Virol. 64: 435–40. pmid:11468727
  53. 53. Ramachandran S, Purdy MA, Xia G, Campo DS, Dimitrova ZE, Teshale EH, et al. Recent Population Expansions of Hepatitis B Virus in the United States. J Virol. 88: 13971–13980. pmid:25187549
  54. 54. Grabarczyk P, Garmiri P, Liszewski G, Doucet D, Sulkowska E, Brojer E, et al. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland. J Viral Hepat. 17: 444–52. pmid:19780948
  55. 55. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009/07/04 ed. 101: 1066–1082. pmid:19574418
  56. 56. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, Kurbanov F, et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol. 2006/08/29 ed. 45: 646–653. pmid:16935384
  57. 57. Van der Kuyl AC, Zorgdrager F, Hogema B, Bakker M, Jurriaans S, Back NKT, et al. High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000–2011. BMC Infect Dis. 13: 540. pmid:24225261
  58. 58. McCullough D. Path Between The Seas: The Creation of the Panama Canal, 1870–1914 [Internet]. Simon & Schuster;
    • 59. Ramachandran S, Purdy M a, Xia G-L, Campo DS, Dimitrova ZE, Teshale EH, et al. Recent Population Expansions of Hepatitis B Virus in the United States. J Virol. 88: 13971–80. pmid:25187549